OR WAIT null SECS
The meeting, to be held jointly with the European Centre for Disease Prevention and Control, is part of the agency’s effort to raise awareness about the threat of antimicrobial resistance.
On Sept. 12, 2017, the European Medicines Agency (EMA) announced a joint meeting with the European Centre for Disease Prevention and Control (ECDC), to be held on Sept. 19, 2017 in London, to discuss the threat of antimicrobial resistance. The meeting will be attended by representatives of the World Health Organization, the European Commission, European Union Member States, patients’ and consumers’ organizations, healthcare professionals, and academics.
The purpose of the meeting is to raise awareness of the threat of antimicrobial resistance and to understand how EMA and ECDC can support European healthcare initiatives against the threat. According to EMA, the threat is rising, with a growing number of infections becoming increasingly resistant to antibiotics. This resistance makes treatment difficult, and EMA and other agencies feel the fight requires a global collaboration.
The draft agenda for the meeting includes overviews of EMA’s and ECDC’s efforts and how other organizations can join in with those efforts. The meeting will be broadcast live on EMA’s website, and a report will be published after the event.